These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5797155)

  • 1. The case for an adjuvanted equine influenza vaccine.
    Kucera CJ
    J Am Vet Med Assoc; 1969 Jul; 155(2):281-4. PubMed ID: 5797155
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineral oil adjuvants: biological and chemical studies.
    Murray R; Cohen P; Hardegree MC
    Ann Allergy; 1972 Mar; 30(3):146-51. PubMed ID: 4622115
    [No Abstract]   [Full Text] [Related]  

  • 3. New metabolizable immunologic adjuvant for human use. 5. Evaluation of highly purified influenza-virus vaccine in adjuvant 65.
    Weibel RE; Woodhour AF; Stokes J; Metzgar DP; Hilleman MR
    N Engl J Med; 1967 Jan; 276(2):78-84. PubMed ID: 6015520
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience in the United Kingdom with oil adjuvant influenza vaccines.
    Perkins FT
    Ann Allergy; 1972 May; 30(5):288-91. PubMed ID: 5063341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Protective effect of the domestic oil adjuvant vaccine against influenza (1 year after vaccination)].
    Bervar M; Papo I; Piscević S; Duknić M
    Vojnosanit Pregl; 1971 Oct; 28(10):505-11. PubMed ID: 5134859
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.
    Kuroda Y; Nacionales DC; Akaogi J; Reeves WH; Satoh M
    Biomed Pharmacother; 2004 Jun; 58(5):325-37. PubMed ID: 15194169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic responses and adverse reactions to Freund's-adjuvanted porcine zona pellucida immuno-contraceptives in domestic cats.
    Munson L; Harrenstien LA; Acton AE; Graham PA; Chassy LM; Kirkpatrick JF
    Vaccine; 2005 Dec; 23(48-49):5646-54. PubMed ID: 16171906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Freund's adjuvants.
    Brown EA
    Rev Allergy; 1969 May; 23(5):389-400. PubMed ID: 4892576
    [No Abstract]   [Full Text] [Related]  

  • 9. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.
    Levie K; Leroux-Roels I; Hoppenbrouwers K; Kervyn AD; Vandermeulen C; Forgus S; Leroux-Roels G; Pichon S; Kusters I
    J Infect Dis; 2008 Sep; 198(5):642-9. PubMed ID: 18576945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of parenteral administration of mineral oil adjuvant in parturient cattle on immunoglobulin secretion in colostrum and milk.
    De Cueninck BJ
    Am J Vet Res; 1981 Mar; 42(3):478-80. PubMed ID: 7271013
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
    Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant disease-prevention with complete Freund's adjuvant and with mineral oil alone.
    Cozine WS; Stanfield AB; Stephens CA; Mazur MT
    Proc Soc Exp Biol Med; 1973 Jun; 143(2):528-30. PubMed ID: 4709020
    [No Abstract]   [Full Text] [Related]  

  • 14. CpG motif-based adjuvant as a replacement for Freund's complete adjuvant in a recombinant LHRH vaccine.
    Conforti VA; de Avila DM; Cummings NS; Zanella R; Wells KJ; Ulker H; Reeves JJ
    Vaccine; 2008 Feb; 26(7):907-13. PubMed ID: 18201806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
    Atmar RL; Keitel WA; Patel SM; Katz JM; She D; El Sahly H; Pompey J; Cate TR; Couch RB
    Clin Infect Dis; 2006 Nov; 43(9):1135-42. PubMed ID: 17029131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental studies on the problem of the mechanism of action of Freund's adjuvant].
    FINGER H
    Arch Hyg Bakteriol; 1962 Feb; 146():61-9. PubMed ID: 13892949
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methodical modifications to optimize granulomatous lung changes in animal experiment (author's transl)].
    Eckert H; Lux M; Szymanska D
    Z Erkr Atmungsorgane; 1981 May; 157(2):230-2. PubMed ID: 7314698
    [No Abstract]   [Full Text] [Related]  

  • 18. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.
    Ansaldi F; Bacilieri S; Durando P; Sticchi L; Valle L; Montomoli E; Icardi G; Gasparini R; Crovari P
    Vaccine; 2008 Mar; 26(12):1525-9. PubMed ID: 18294741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.